Literature DB >> 17202596

Signaling pathways implicated in hematopoietic progenitor cell proliferation and differentiation.

Diana Bugarski1, Aleksandra Krstic, Slavko Mojsilovic, Marija Vlaski, Marijana Petakov, Gordana Jovcic, Nevenka Stojanovic, Pavle Milenkovic.   

Abstract

The objective of this study was to investigate the signal transduction pathways associated with the clonal development of myeloid and erythroid progenitor cells. The contribution of particular signaling molecules of protein tyrosine kinases (PTKs), mitogen-activated protein (MAP) kinase, and PI-3 kinase signaling to the growth of murine bone marrow colony forming unit-granulocyte-macrophage (CFU-GM) and erythroid (burst forming unit-erythroid [BFU-E] and colony forming unit-erythroid [CFU-E]) progenitors was examined in studies performed in the presence or absence of specific signal transduction inhibitors. The results clearly pointed to different signal transducing intermediates that are involved in cell proliferation and differentiation depending on the cell lineage, as well as on the progenitors' maturity. Lineage-specific differences were obtained when chemical inhibitors specific for receptor- or nonreceptor-PTKs, as well as for the main groups of distinctly regulated MAPK cascades, were used because all of these compounds suppressed the growth of erythroid progenitors, with no major effects on myeloid progenitors. At the same time, differential involvement of MEK/extracellular signal-regulated kinase (ERK) MAPK transduction pathway was observed in the proliferation and/or differentiation of early, BFU-E, and late, CFU-E, erythroid progenitor cells. The results also demonstrated that phosphatydylinositol (PI)-3 kinase and nuclear factor kappaB (NF-kappaB) transcriptional factor were required for maintenance of both myeloid and erythroid progenitor cell function. Overall, the data obtained indicated that committed hematopoietic progenitors express a certain level of constitutive signaling activity that participates in the regulation of normal steady-state hematopoiesis and point to the importance of evaluating the impact of signal transduction inhibitors on normal bone marrow when used as potential therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17202596

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  6 in total

1.  UCP2 modulates cell proliferation through the MAPK/ERK pathway during erythropoiesis and has no effect on heme biosynthesis.

Authors:  Alvaro Elorza; Brigham Hyde; Hanna K Mikkola; Sheila Collins; Orian S Shirihai
Journal:  J Biol Chem       Date:  2008-08-07       Impact factor: 5.157

Review 2.  Vitamin D3-driven signals for myeloid cell differentiation--implications for differentiation therapy.

Authors:  Philip J Hughes; Ewa Marcinkowska; Elzbieta Gocek; George P Studzinski; Geoffrey Brown
Journal:  Leuk Res       Date:  2009-10-06       Impact factor: 3.156

3.  Comparative analysis of gene transcripts for cell signaling receptors in bone marrow-derived hematopoietic stem/progenitor cell and mesenchymal stromal cell populations.

Authors:  Khairul Anam; Thomas A Davis
Journal:  Stem Cell Res Ther       Date:  2013-09-16       Impact factor: 6.832

Review 4.  Leukemia and benzene.

Authors:  Robert Snyder
Journal:  Int J Environ Res Public Health       Date:  2012-08-14       Impact factor: 3.390

5.  Clinical significance of sunitinib-associated macrocytosis in metastatic renal cell carcinoma.

Authors:  Maria T Bourlon; Dexiang Gao; Sara Trigero; Julia E Clemons; Kathryn Breaker; Elaine T Lam; Thomas W Flaig
Journal:  Cancer Med       Date:  2016-10-19       Impact factor: 4.452

6.  The Role of TAL1 in Hematopoiesis and Leukemogenesis.

Authors:  E R Vagapova; P V Spirin; T D Lebedev; V S Prassolov
Journal:  Acta Naturae       Date:  2018 Jan-Mar       Impact factor: 1.845

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.